HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Idiopathic retroperitoneal fibrosis: combined steroid and endourologic treatment].

Abstract
Review of 7 patients with idiopathic retroperitoneal fibrosis (IRF), treated with a combination of corticosteroids (6-methyl-prednisolone) and endourological procedures. The presentation symptom was lumbar pain in all 7 cases. Mean creatinine (Cr) levels were 5.4 mg/dl, with mean erythrocyte sedimentation rate (ESR) of 114. Three (43%) patients were positive to rheumatoid factor (RF) and had raised IgG. Definite diagnosis was achieved in all cases by CAT, including puncture biopsy in 1; all 7 (100%) cases were bilateral. With an average follow-up of 3 years, clinical evolution is satisfactory in all 7 cases. Mean control Cr is 1.2 mg/dl and mean ESR 19. CAT showed disappearance of fibrotic plaque in all cases. One patient relapsed when maintenance therapy was discontinued but responded again to a new therapy course. No steroid therapy-related complications were seen. The association of conservative steroid therapy and endourological procedures is a very low morbidity, sensible alternative in the management of benign retroperitoneal fibrosis where CAT and MNR are the primary diagnostic techniques.
AuthorsF Gómez Veiga, V Chantada Abal, A Sousa Escandón, J Rodríguez García, J Sánchez Rodríguez, M González Martín
JournalActas urologicas espanolas (Actas Urol Esp) Vol. 16 Issue 1 Pg. 17-24 (Jan 1992) ISSN: 0210-4806 [Print] Spain
Vernacular TitleFibrosis retroperitoneal idiopática: tratamiento combinado esteroideo y endourológico.
PMID1590069 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Methylprednisolone
Topics
  • Adult
  • Aged
  • Algorithms
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Methylprednisolone (therapeutic use)
  • Middle Aged
  • Nephrostomy, Percutaneous
  • Retroperitoneal Fibrosis (diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: